Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature-Reference-Cited by-同舟云学术

Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature

Published:2010-04-19 Issue:7 Volume:11 Page:1167-1181
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Mancini Michele,Perna Giampaolo,Rossi Andrea,Petralia Antonino

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656561003747441

Reference84 articles.

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders text revision: DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000

2. Functional Impact and Health Utility of Anxiety Disorders in Primary Care Outpatients

3. Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication

4. The epidemiology of generalized anxiety disorder in Europe

5. The Selective GABA Reuptake Inhibitor Tiagabine for the Treatment of Generalized Anxiety Disorder

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Duloxetine versus ‘active’ placebo, placebo or no intervention for major depressive disorder; a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis;Systematic Reviews;2021-06-09

2. Psychiatric comorbidity and order of condition onset among patients seeking treatment for chronic pain and opioid use disorder;Drug and Alcohol Dependence;2021-04

3. Duloxetine usage in depression;The Neuroscience of Depression;2021

4. Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series;Journal of Addictive Diseases;2020-02-17

5. Experimental investigations, cytotoxicity and cellular uptake outcomes of physically modified duloxetine HCl inclusion complexes;Polymer Bulletin;2019-01-28